Innoviva (INVA) Non-Current Assets (2010 - 2026)
Innoviva posted quarterly Non-Current Assets of $1.1 billion for Q1 2026, up 58.24% year-on-year from $672.4 million in Q1 2025, and up 17.22% on a QoQ basis from $907.6 million in Q4 2025.
Innoviva (INVA) has 17 years of Non-Current Assets data on file, last reported at $1.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 58.24% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $3.3 billion (up 2.58% YoY), and the FY2025 full-year result was $907.6 million, up 21.55% from the prior year.
- Non-Current Assets for Q1 2026 stood at $1.1 billion, up from $907.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2026 and bottomed at $59.6 million in Q3 2022.
- The 5-year median for Non-Current Assets is $737.3 million (2022), against an average of $557.1 million.
- Peak annual rise in Non-Current Assets reached 5746.67% in 2022, while the deepest fall reached 90.27% in 2022.
- A 5-year view of Non-Current Assets shows it stood at $59.6 million in 2022, then gained by 27.73% to $76.2 million in 2023, then jumped by 880.3% to $746.8 million in 2024, then climbed by 21.55% to $907.6 million in 2025, then rose by 17.22% to $1.1 billion in 2026.
- The last three Non-Current Assets figures came in at $1.1 billion (Q1 2026), $907.6 million (Q4 2025), and $72.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 1.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Bn |
| Dec 31, 2025 | 907.65 Mn |
| Sep 30, 2025 | 72.59 Mn |
| Jun 30, 2025 | 681.79 Mn |
| Mar 31, 2025 | 672.37 Mn |
| Dec 31, 2024 | 746.75 Mn |
| Sep 30, 2024 | 75.85 Mn |
| Jun 30, 2024 | 866.64 Mn |
| Mar 31, 2024 | 956.27 Mn |
| Dec 31, 2023 | 76.18 Mn |
| Sep 30, 2023 | 76.18 Mn |
| Jun 30, 2023 | 794.70 Mn |
| Mar 31, 2023 | 833.32 Mn |
| Dec 31, 2022 | 59.64 Mn |
| Sep 30, 2022 | 59.64 Mn |
| Jun 30, 2022 | 737.31 Mn |
| Mar 31, 2022 | 789.65 Mn |
| Dec 31, 2021 | 612.72 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 640.89 Mn |
| Mar 31, 2021 | 715.36 Mn |
| Dec 31, 2020 | 657.51 Mn |
| Sep 30, 2020 | 28.65 Mn |
| Jun 30, 2020 | 379.43 Mn |
| Mar 31, 2020 | 321.10 Mn |
| Dec 31, 2019 | 293.59 Mn |
| Sep 30, 2019 | 309.16 Mn |
| Jun 30, 2019 | 324.62 Mn |
| Mar 31, 2019 | 338.60 Mn |
| Dec 31, 2018 | 349.15 Mn |
| Sep 30, 2018 | 156.56 Mn |
| Jun 30, 2018 | 160.03 Mn |
| Mar 31, 2018 | 163.50 Mn |
| Dec 31, 2017 | 166.97 Mn |
| Sep 30, 2017 | 170.46 Mn |
| Jun 30, 2017 | 173.96 Mn |
| Mar 31, 2017 | 177.45 Mn |
| Dec 31, 2016 | 180.95 Mn |
| Sep 30, 2016 | 184.42 Mn |
| Jun 30, 2016 | 187.69 Mn |
| Mar 31, 2016 | 191.12 Mn |
| Dec 31, 2015 | 194.61 Mn |
| Sep 30, 2015 | 213.88 Mn |
| Jun 30, 2015 | 218.13 Mn |
| Mar 31, 2015 | 226.31 Mn |
| Dec 31, 2014 | 269.47 Mn |
| Sep 30, 2014 | 280.24 Mn |
| Jun 30, 2014 | 252.45 Mn |
| Mar 31, 2014 | 215.84 Mn |
| Dec 31, 2013 | 198.06 Mn |
| Sep 30, 2013 | 143.68 Mn |
| Jun 30, 2013 | 137.47 Mn |
| Mar 31, 2013 | 117.01 Mn |
| Dec 31, 2012 | 107.45 Mn |
| Sep 30, 2012 | 101.41 Mn |
| Jun 30, 2012 | 96.04 Mn |
| Mar 31, 2012 | 13.40 Mn |
| Dec 31, 2011 | 14.02 Mn |
| Sep 30, 2011 | 14.16 Mn |
| Jun 30, 2011 | 14.50 Mn |
| Dec 31, 2010 | 14.85 Mn |